Your browser doesn't support javascript.
loading
Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer.
Ji, Jin; Chen, Rui; Zhao, Lin; Xu, Yalong; Cao, Zhi; Xu, Huan; Chen, Xi; Shi, Xiaolei; Zhu, Yasheng; Lyu, Ji; Jiang, Junfeng; Wang, Yue; Zhou, Tie; He, Jingyi; Wei, Xuedong; Wu, Jason Boyang; Yang, Bo; Wang, Fubo.
Afiliação
  • Ji J; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Chen R; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Zhao L; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Xu Y; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Cao Z; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Xu H; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Chen X; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Shi X; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Zhu Y; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Lyu J; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Jiang J; Division of Urology and Transplantation, Department of Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital and Hospital of The University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
  • Wang Y; Research Center of Developmental Biology, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Zhou T; Research Center of Developmental Biology, Naval Medical University (Second Military Medical University), Shanghai, China.
  • He J; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Wei X; Department of Urology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Wu JB; Department of Urology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Yang B; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, 99202, USA.
  • Wang F; Department of Urology, Shanghai Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China. yangbochanghai@126.com.
Mol Cancer ; 20(1): 58, 2021 03 30.
Article em En | MEDLINE | ID: mdl-33785037
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / RNA Mensageiro / Biomarcadores Tumorais / Exossomos / Ácidos Nucleicos Livres Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / RNA Mensageiro / Biomarcadores Tumorais / Exossomos / Ácidos Nucleicos Livres Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China